Literature DB >> 11526963

Abnormal presynaptic catecholamine regulation in a hyperactive SNAP-25-deficient mouse mutant.

M D Jones1, M E Williams, E J Hess.   

Abstract

The consequences of a reduction in the presynaptic protein, SNAP-25, were investigated to determine the neurochemical basis of the marked hyperlocomotor activity in coloboma (Cm/+) mice. SNAP-25 is part of the minimal presynaptic machinery necessary for exocytotic neurotransmitter release. Reserpine treatment was used to deplete vesicular stores of catecholamines. Coloboma mice were more sensitive to the effects of reserpine than control mice. However, presynaptic regulation of dopamine (DA) release, as assessed by low-dose apomorphine challenge, was intact. There were region-specific reductions in in vivo tyrosine hydroxylation and the DA metabolites homovanillic acid (HVA) and 3,4-dihydroxyphenylacetic acid (DOPAC) in the striatum and nucleus accumbens of Cm/+ mice. While hyperactivity is often associated with changes in DA concentration, norepinephrine (NE) concentration was significantly increased in the striatum and nucleus accumbens of the hyperactive mutant. The increase in NE may regulate the hyperactivity in these mice, as suggested by current hypotheses of the mechanisms underlying attention-deficit hyperactivity disorder (ADHD) and Tourette's syndrome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11526963     DOI: 10.1016/s0091-3057(01)00481-6

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  19 in total

1.  D2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHD.

Authors:  Xueliang Fan; Ming Xu; Ellen J Hess
Journal:  Neurobiol Dis       Date:  2009-10-22       Impact factor: 5.996

2.  Abnormal latent inhibition and impulsivity in coloboma mice, a model of ADHD.

Authors:  Kristy J Bruno; Christopher S Freet; Robert C Twining; Kiyoshi Egami; Patricia S Grigson; Ellen J Hess
Journal:  Neurobiol Dis       Date:  2006-10-24       Impact factor: 5.996

Review 3.  Exploring the Validity of Proposed Transgenic Animal Models of Attention-Deficit Hyperactivity Disorder (ADHD).

Authors:  June Bryan de la Peña; Irene Joy Dela Peña; Raly James Custodio; Chrislean Jun Botanas; Hee Jin Kim; Jae Hoon Cheong
Journal:  Mol Neurobiol       Date:  2017-05-22       Impact factor: 5.590

Review 4.  SNARE complex in developmental psychiatry: neurotransmitter exocytosis and beyond.

Authors:  Renata Basso Cupertino; Djenifer B Kappel; Cibele Edom Bandeira; Jaqueline Bohrer Schuch; Bruna Santos da Silva; Diana Müller; Claiton Henrique Dotto Bau; Nina Roth Mota
Journal:  J Neural Transm (Vienna)       Date:  2016-02-08       Impact factor: 3.575

Review 5.  Annual Research Review: Transgenic mouse models of childhood-onset psychiatric disorders.

Authors:  Holly R Robertson; Guoping Feng
Journal:  J Child Psychol Psychiatry       Date:  2011-02-10       Impact factor: 8.982

6.  D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHD.

Authors:  Xueliang Fan; Ellen J Hess
Journal:  Neurobiol Dis       Date:  2006-12-29       Impact factor: 5.996

7.  Role of SNAP25 explored in eastern Indian attention deficit hyperactivity disorder probands.

Authors:  Kanyakumarika Sarkar; Nipa Bhaduri; Paramita Ghosh; Swagata Sinha; Anirban Ray; Anindita Chatterjee; Kanchan Mukhopadhyay
Journal:  Neurochem Res       Date:  2011-10-14       Impact factor: 3.996

Review 8.  Poor response inhibition: at the nexus between substance abuse and attention deficit/hyperactivity disorder.

Authors:  Stephanie M Groman; Alex S James; J David Jentsch
Journal:  Neurosci Biobehav Rev       Date:  2008-08-22       Impact factor: 8.989

Review 9.  The Association of SNAP25 Gene Polymorphisms in Attention Deficit/Hyperactivity Disorder: a Systematic Review and Meta-Analysis.

Authors:  Yun-Sheng Liu; Xuan Dai; Wei Wu; Fang-Fen Yuan; Xue Gu; Jian-Guo Chen; Ling-Qiang Zhu; Jing Wu
Journal:  Mol Neurobiol       Date:  2016-03-03       Impact factor: 5.590

10.  A novel mechanism and treatment target for presynaptic abnormalities in specific striatal regions in schizophrenia.

Authors:  Vilte E Barakauskas; Clare L Beasley; Alasdair M Barr; Athena R Ypsilanti; Hong-Ying Li; Allen E Thornton; Hubert Wong; Gorazd Rosokilja; J John Mann; Branislav Mancevski; Zlatko Jakovski; Natasha Davceva; Boro Ilievski; Andrew J Dwork; Peter Falkai; William G Honer
Journal:  Neuropsychopharmacology       Date:  2010-01-13       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.